Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 2Withdrawn 1Unknown 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 4Sarcoma 2Gynecologic 2Thoracic 1Plasma cell 1Dermatologic 1Breast 1

Conditions

Sarcoma 2Sarcoma, Kaposi 1Histiocytoma, Malignant Fibrous 1Hemangiosarcoma 1

Interventions

Doxorubicin 25Cyclophosphamide 24pembrolizumab 20Specimen Handling 19Temozolomide 16Magnetic Resonance Spectroscopy 15Surgical Procedures, Operative 14Radiotherapy 13Blood Specimen Collection 13Biopsy 13atezolizumab 12Gemcitabine 12fludarabine 11Vincristine 11Ifosfamide 11X-Rays 8Trabectedin 8Nivolumab 8Irinotecan 8Imatinib Mesylate 8Drug Therapy 8cabozantinib 7Surveys and Questionnaires 7Radiation 7liposomal doxorubicin 5abemaciclib 5Sunitinib 5Standard of Care 5Radiation Dose Hypofractionation 5Dactinomycin 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Propranolol × Sarcoma × Clear all
NCT06445166 2026-04-06

Propranolol for the Treatment of Kaposi Sarcoma in Adults

Washington University School of Medicine

Phase 2 Recruiting
25 enrolled
Sarcoma

Sarcoma, Sarcoma, Kaposi

NCT05961761 2023-07-27

PROPANE

Herlev and Gentofte Hospital

Phase 2 Recruiting
80 enrolled
Sarcoma

Hemangiosarcoma, Sarcoma, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡